Heron Therapeutics Inc (HRTX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché HRTX Giù? Forum Previsione Frazionamento azionario

Heron Therapeutics Inc Azioni (HRTX) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	4.38% 37.20	38.90	40.78	32.81	36.02
Cost Of Revenue	16.55% 9.857	8.457	10.23	9.458	10.52
Gross Profit	10.19% 27.34	30.45	30.55	23.35	25.51
Operating Expenses	6.18% 28.98	27.29	26.38	27.81	31.95
Benefits Costs and Expenses	6.18% 28.98	27.29	26.38	27.81	31.95
Costs And Expenses	6.18% 28.98	27.29	26.38	27.81	31.95
Operating Income/Loss	151.90% -1.637	3.154	4.173	-4.458	-6.445
Income/Loss From Continuing Operations Before Tax	211.95% 8.22	2.635	14.40	5.00	-9.235
Income/Loss From Continuing Operations After Tax	190.36% -2.381	2.635	3.663	-4.848	-9.235
Net Income/Loss	190.36% -2.381	2.635	3.663	-4.848	-9.235
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.35% 154.02	153.49	0.236	152.83	152.31
Diluted Average Shares	21.79% 154.02	196.92	0.236	152.83	152.31
Basic Earnings Per Share	200.00% -0.02	0.02	0.02	-0.03	-0.06
Diluted Earnings Per Share	300.00% -0.02	0.01	0.02	-0.03	-0.06
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.30

0.64%

GMAB

$28.71

0.35%

INCY

$101.57

8.65%

BNTX

$103.95

0.04%

ONC

$311.86

0.44%

INSM

$186.23

1.78%